August 2021

TJP Labs Completes Multi-Million Dollar Investment Round to Continue Global Expansion into Modern Oral Nicotine Manufacturing

PICKERING, Ontario, Aug. 31, 2021 (GLOBE NEWSWIRE) — TJP Labs Inc. (“TJP Labs”), one of North America’s leading full-service contract manufacturers of next-generation nicotine products, announced its launch of Canada’s first modern oral nicotine contract manufacturing facility for buccal nicotine pouches. TJP Labs will provide international brands (and when authorized

>

TRIO Enrols First Patient in Global Phase 3 Giredestrant Early Breast Cancer Trial

EDMONTON, Alberta, Aug. 31, 2021 (GLOBE NEWSWIRE) — Translational Research in Oncology (TRIO), a global academic clinical research organization, announced today enrolment of first patient in the LidERA Breast Cancer (TRIO045) trial, a Phase 3 randomized, multi-center, open-label global clinical trial of adjuvant endocrine therapy, giredestrant (GDC-9545) sponsored by F.

>

Global Dairy Platform Announces New Board Chair

Hein Schumacher ROSEMONT, Ill., Aug. 31, 2021 (GLOBE NEWSWIRE) — Global Dairy Platform (GDP), a not-for-profit industry association representing the international dairy sector, today announced the appointment of Hein Schumacher, Chief Executive Officer of Royal FrieslandCampina, as Chair of GDP’s Board of Directors. Schumacher succeeds Rick Smith, President and Chief

>

nCino to Participate in Upcoming Middle East Banking Innovation Summit

WILMINGTON, N.C. and DUBAI, United Arab Emirates, Aug. 31, 2021 (GLOBE NEWSWIRE) — nCino, Inc. (NASDAQ: NCNO), a pioneer in cloud banking and digital transformation solutions for the global financial services industry, today announced its participation in the Middle East Banking Innovation Summit Plus 2021 (MEBIS Plus 2021) on September

>

Junshi Biosciences Announces 2021 Interim Financial Results and Provides Corporate Updates

SHANGHAI, China, Aug. 31, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial results for the six months ended June 30, 2021 and provided corporate updates. First Half 2021 Financial Highlights Total revenue reached RMB 2,114 […]

>